EDS-related clinical manifestations were evaluated in all 21 patients with CAH-X and in some of their relatives carrying the continuous deletion involving the CYP21A2 and part of the TNXB gene (Table 2, Table 3 and Table 4). The gene discussed is CYP21A2; the disease is Ehlers-Danlos syndrome.